These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38804742)

  • 21. Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases.
    Lee CT; Barocas D; Globe DR; Oefelein MG; Colayco DC; Bruno A; O'Day K; Bramley T
    J Urol; 2012 Dec; 188(6):2114-9. PubMed ID: 23083857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
    Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
    J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
    Fujita N; Hatakeyama S; Momota M; Kido K; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2020 Aug; 38(8):684.e17-684.e24. PubMed ID: 32278732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study.
    Lee HW; Lee HH; Park EY; Park WS; Kim SH; Joung JY; Chung J; Seo HK
    J Urol; 2023 Jan; 209(1):131-139. PubMed ID: 36250938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical therapy for bladder cancer.
    Patel SG; Cohen A; Weiner AB; Steinberg GD
    Expert Opin Pharmacother; 2015 Apr; 16(6):889-901. PubMed ID: 25773220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
    Irani J
    Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors.
    Zhou Z; Zhao S; Lu Y; Wu J; Li Y; Gao Z; Yang D; Cui Y
    World J Urol; 2019 Jun; 37(6):1075-1084. PubMed ID: 30612154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
    Nielsen ME; Smith AB; Pruthi RS; Guzzo TJ; Amiel G; Shore N; Lotan Y
    BJU Int; 2012 Oct; 110(7):967-72. PubMed ID: 22487336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology.
    Lone Z; Benidir T; Wood A; Campbell RA; Alaghehbandan R; Li J; Haber GP; Eltemamy M; Haywood SC; Weight CJ; Lee BH; Almassi N
    Urol Oncol; 2024 Mar; 42(3):71.e1-71.e7. PubMed ID: 38135626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
    Madeb R; Golijanin D; Noyes K; Fisher S; Stephenson JJ; Long SR; Knopf J; Lyman GH; Messing EM
    Cancer; 2009 Jun; 115(12):2660-70. PubMed ID: 19455607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer.
    Hendricksen K; Witjes JA
    Curr Opin Urol; 2007 Sep; 17(5):352-7. PubMed ID: 17762630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer.
    Cookson MS; Chang SS; Oefelein MG; Gallagher JR; Schwartz B; Heap K
    J Urol; 2012 May; 187(5):1571-6. PubMed ID: 22425105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer.
    Burks FN; Liu AB; Suh RS; Schuster TG; Bradford T; Moylan DA; Knapp PM; Murtagh DS; Dunn RL; Montie JE; Miller DC
    J Urol; 2012 Dec; 188(6):2108-13. PubMed ID: 23083865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.
    Sfakianos JP; Kim PH; Hakimi AA; Herr HW
    J Urol; 2014 Feb; 191(2):341-5. PubMed ID: 23973518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis.
    Zhou W; Liu J; Mao D; Hu C; Gao D
    PLoS One; 2022; 17(10):e0276453. PubMed ID: 36269742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer.
    Ruan Q; Ding D; Wang B; He C; Ren X; Feng Z; Pang Z; Wang J; Zhang X; Tang H; Wang J; He Q; Lei Z; Liao Q; Luo J; Cui S
    Cancer Biol Med; 2021 Feb; 18(1):308-317. PubMed ID: 33628603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer.
    Joice GA; Bivalacqua TJ; Kates M
    Nat Rev Urol; 2019 Oct; 16(10):599-612. PubMed ID: 31434998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.